Author Correction: Super-enhancer hypermutation alters oncogene expression in B cell lymphoma

Affiliations

• ¹ Institute for Cancer Genetics, Columbia University, New York, NY, USA.
• ² Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India.
• ³ Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
• ⁴ Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
• ⁵ Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
• ⁶ Proteomics and Macromolecular Crystallography Shared Resource, Columbia University, New York, NY, USA.
• ⁷ Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
• ⁸ Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.
• ⁹ Genome Sciences Center, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
• ¹⁰ Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
• ¹¹ Institute for Cancer Genetics, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu.
• ¹² Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu.
• ¹³ Department of Pathology and Cell Biology, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu.
• ¹⁴ Institute for Cancer Genetics, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.
• ¹⁵ Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.
• ¹⁶ Department of Pathology and Cell Biology, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.
• ¹⁷ Department of Genetics & Development, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.
• ¹⁸ Department of Microbiology & Immunology, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.